Literature DB >> 7982959

The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-alpha gene transcription.

P G McCaffrey1, A E Goldfeld, A Rao.   

Abstract

The tumor necrosis factor-alpha (TNF alpha) gene is an immediate early gene in activated T cells, in that it is rapidly induced without a requirement for protein synthesis. Maximal induction of TNF alpha mRNA can be induced by treatment of T cells with calcium ionophores alone, via a calcineurin-dependent process that is blocked by cyclosporin A. We have previously identified a promoter element, kappa 3, that is required for calcium-stimulated, cyclosporin A-sensitive induction of the TNF alpha gene in activated T cells. Here, we demonstrate that the kappa 3 binding factor contains NFATp, a cyclosporin-sensitive DNA-binding protein required for interleukin-2 gene transcription. NFATp binds to two sites within the kappa 3 element, and occupancy of both sites is required for TNF alpha gene induction. Thus, although the kappa 3 element has little sequence similarity to other NFATp-binding sites, it appears to function as a cyclosporin-sensitive promoter element in T cells by virtue of its ability to bind NFATp. The involvement of NFATp in transcriptional activation of both the interleukin-2 and TNF alpha genes suggests that this factor plays an important role in the coordinate induction of multiple cytokine genes, starting at the earliest stages of T cell activation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7982959

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Signaling to gene expression: calcium, calcineurin and NFAT.

Authors:  Anjana Rao
Journal:  Nat Immunol       Date:  2009-01       Impact factor: 25.606

2.  A novel splice variant of the transcription factor Nrf1 interacts with the TNFalpha promoter and stimulates transcription.

Authors:  E E Prieschl; V Novotny; R Csonga; D Jaksche; A Elbe-Bürger; W Thumb; M Auer; G Stingl; T Baumruker
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

Review 3.  Transcriptional control of the TNF gene.

Authors:  James V Falvo; Alla V Tsytsykova; Anne E Goldfeld
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

4.  T-cell receptor stimulation elicits an early phase of activation and a later phase of deactivation of the transcription factor NFAT1.

Authors:  C Loh; J A Carew; J Kim; P G Hogan; A Rao
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

5.  Calcineurin-dependent nuclear translocation of a murine transcription factor NFATx: molecular cloning and functional characterization.

Authors:  J Liu; N Koyano-Nakagawa; Y Amasaki; F Saito-Ohara; T Ikeuchi; S Imai; T Takano; N Arai; T Yokota; K Arai
Journal:  Mol Biol Cell       Date:  1997-01       Impact factor: 4.138

6.  Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter.

Authors:  J V Falvo; A M Uglialoro; B M Brinkman; M Merika; B S Parekh; E Y Tsai; H C King; A D Morielli; E G Peralta; T Maniatis; D Thanos; A E Goldfeld
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

Review 7.  NFAT as cancer target: mission possible?

Authors:  Jiang-Jiang Qin; Subhasree Nag; Wei Wang; Jianwei Zhou; Wei-Dong Zhang; Hui Wang; Ruiwen Zhang
Journal:  Biochim Biophys Acta       Date:  2014-07-26

8.  Cell-type-specific regulation of the human tumor necrosis factor alpha gene in B cells and T cells by NFATp and ATF-2/JUN.

Authors:  E Y Tsai; J Yie; D Thanos; A E Goldfeld
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

Review 9.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

10.  Doxorubicin-mediated apoptosis in glioma cells requires NFAT3.

Authors:  Sreelatha Gopinath; Sravan K Vanamala; Meena Gujrati; Jeffrey D Klopfenstein; Dzung H Dinh; Jasti S Rao
Journal:  Cell Mol Life Sci       Date:  2009-09-27       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.